Literature DB >> 18188699

Partial least squares Cox regression for genome-wide data.

Ståle Nygård1, Ornulf Borgan, Ole Christian Lingjaerde, Hege Leite Størvold.   

Abstract

Most methods for survival prediction from high-dimensional genomic data combine the Cox proportional hazards model with some technique of dimension reduction, such as partial least squares regression (PLS). Applying PLS to the Cox model is not entirely straightforward, and multiple approaches have been proposed. The method of Park etal. (Bioinformatics 18(Suppl. 1):S120-S127, 2002) uses a reformulation of the Cox likelihood to a Poisson type likelihood, thereby enabling estimation by iteratively reweighted partial least squares for generalized linear models. We propose a modification of the method of Park et al. (2002) such that estimates of the baseline hazard and the gene effects are obtained in separate steps. The resulting method has several advantages over the method of Park et al. (2002) and other existing Cox PLS approaches, as it allows for estimation of survival probabilities for new patients, enables a less memory-demanding estimation procedure, and allows for incorporation of lower-dimensional non-genomic variables like disease grade and tumor thickness. We also propose to combine our Cox PLS method with an initial gene selection step in which genes are ordered by their Cox score and only the highest-ranking k% of the genes are retained, obtaining a so-called supervised partial least squares regression method. In simulations, both the unsupervised and the supervised version outperform other Cox PLS methods.

Entities:  

Mesh:

Year:  2008        PMID: 18188699     DOI: 10.1007/s10985-007-9076-7

Source DB:  PubMed          Journal:  Lifetime Data Anal        ISSN: 1380-7870            Impact factor:   1.588


  9 in total

1.  Partial Cox regression analysis for high-dimensional microarray gene expression data.

Authors:  Hongzhe Li; Jiang Gui
Journal:  Bioinformatics       Date:  2004-08-04       Impact factor: 6.937

2.  Predicting survival from microarray data--a comparative study.

Authors:  H M Bøvelstad; S Nygård; H L Størvold; M Aldrin; Ø Borgan; A Frigessi; O C Lingjaerde
Journal:  Bioinformatics       Date:  2007-06-06       Impact factor: 6.937

3.  Gene expression profiling predicts clinical outcome of breast cancer.

Authors:  Laura J van 't Veer; Hongyue Dai; Marc J van de Vijver; Yudong D He; Augustinus A M Hart; Mao Mao; Hans L Peterse; Karin van der Kooy; Matthew J Marton; Anke T Witteveen; George J Schreiber; Ron M Kerkhoven; Chris Roberts; Peter S Linsley; René Bernards; Stephen H Friend
Journal:  Nature       Date:  2002-01-31       Impact factor: 49.962

4.  Cross-validated Cox regression on microarray gene expression data.

Authors:  Hans C van Houwelingen; Tako Bruinsma; Augustinus A M Hart; Laura J Van't Veer; Lodewyk F A Wessels
Journal:  Stat Med       Date:  2006-09-30       Impact factor: 2.373

5.  Cross-validation in survival analysis.

Authors:  P J Verweij; H C Van Houwelingen
Journal:  Stat Med       Date:  1993-12-30       Impact factor: 2.373

6.  Linking gene expression data with patient survival times using partial least squares.

Authors:  Peter J Park; Lu Tian; Isaac S Kohane
Journal:  Bioinformatics       Date:  2002       Impact factor: 6.937

7.  Partial least squares proportional hazard regression for application to DNA microarray survival data.

Authors:  Danh V Nguyen; David M Rocke
Journal:  Bioinformatics       Date:  2002-12       Impact factor: 6.937

8.  Predicting patient survival from microarray data by accelerated failure time modeling using partial least squares and LASSO.

Authors:  Susmita Datta; Jennifer Le-Rademacher; Somnath Datta
Journal:  Biometrics       Date:  2007-03       Impact factor: 2.571

9.  Semi-supervised methods to predict patient survival from gene expression data.

Authors:  Eric Bair; Robert Tibshirani
Journal:  PLoS Biol       Date:  2004-04-13       Impact factor: 8.029

  9 in total
  8 in total

1.  The additive hazards model with high-dimensional regressors.

Authors:  Torben Martinussen; Thomas H Scheike
Journal:  Lifetime Data Anal       Date:  2009-01-28       Impact factor: 1.588

2.  Supervised two-dimensional functional principal component analysis with time-to-event outcomes and mammogram imaging data.

Authors:  Shu Jiang; Jiguo Cao; Bernard Rosner; Graham A Colditz
Journal:  Biometrics       Date:  2021-12-02       Impact factor: 1.701

3.  MiRKAT-S: a community-level test of association between the microbiota and survival times.

Authors:  Anna Plantinga; Xiang Zhan; Ni Zhao; Jun Chen; Robert R Jenq; Michael C Wu
Journal:  Microbiome       Date:  2017-02-08       Impact factor: 14.650

Review 4.  Challenges in the Integration of Omics and Non-Omics Data.

Authors:  Evangelina López de Maturana; Lola Alonso; Pablo Alarcón; Isabel Adoración Martín-Antoniano; Silvia Pineda; Lucas Piorno; M Luz Calle; Núria Malats
Journal:  Genes (Basel)       Date:  2019-03-20       Impact factor: 4.096

5.  Survival prediction from clinico-genomic models--a comparative study.

Authors:  Hege M Bøvelstad; Ståle Nygård; Ornulf Borgan
Journal:  BMC Bioinformatics       Date:  2009-12-13       Impact factor: 3.169

6.  Predicting the survival time for diffuse large B-cell lymphoma using microarray data.

Authors:  Mehri Khoshhali; Hossein Mahjub; Massoud Saidijam; Jalal Poorolajal; Ali Reza Soltanian
Journal:  J Mol Genet Med       Date:  2012-05-23

7.  Comparison of dimension reduction-based logistic regression models for case-control genome-wide association study: principal components analysis vs. partial least squares.

Authors:  Honggang Yi; Hongmei Wo; Yang Zhao; Ruyang Zhang; Junchen Dai; Guangfu Jin; Hongxia Ma; Tangchun Wu; Zhibin Hu; Dongxin Lin; Hongbing Shen; Feng Chen
Journal:  J Biomed Res       Date:  2015-04-20

8.  Classification based on extensions of LS-PLS using logistic regression: application to clinical and multiple genomic data.

Authors:  Caroline Bazzoli; Sophie Lambert-Lacroix
Journal:  BMC Bioinformatics       Date:  2018-09-06       Impact factor: 3.169

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.